-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D637dx9dAbLHXbyqL1HfwR+nYEvkKN+c50/FOE/rgXU0lQMZ3vPqKdUMwvmTodQu Cm18hYAoj57Y2fVsKng+vg== 0001181971-08-000001.txt : 20080401 0001181971-08-000001.hdr.sgml : 20080401 20080401192918 ACCESSION NUMBER: 0001181971-08-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080328 FILED AS OF DATE: 20080401 DATE AS OF CHANGE: 20080401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CARACO PHARMACEUTICAL LABORATORIES LTD CENTRAL INDEX KEY: 0000887708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382505723 STATE OF INCORPORATION: MI FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY DR CITY: DETROIT STATE: MI ZIP: 48202 BUSINESS PHONE: 3138718400 MAIL ADDRESS: STREET 1: 1150 ELIJAH MCCOY DRIVE CITY: DETROIT STATE: MI ZIP: 48202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOVENS DANIEL H CENTRAL INDEX KEY: 0001181971 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 08730985 BUSINESS ADDRESS: BUSINESS PHONE: 9544731027 MAIL ADDRESS: STREET 1: 11781 NW 9TH ST CITY: PLANTATION STATE: FL ZIP: 33325 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-03-28 0 0000887708 CARACO PHARMACEUTICAL LABORATORIES LTD CPD 0001181971 MOVENS DANIEL H 1150 ELIJAH MCCOY DRIVE DETROIT MI 48202 1 1 0 0 Chief Executive Officer Common Stock 2008-03-28 4 S 0 200 17.33 D 44800 D Common Stock 2008-03-28 4 S 0 100 17.34 D 44700 D Common Stock 2008-03-28 4 S 0 100 17.43 D 44600 D Common Stock 2008-03-28 4 S 0 364 17.45 D 44236 D Common Stock 2008-03-28 4 S 0 100 17.47 D 44136 D Common Stock 2008-03-28 4 S 0 200 17.48 D 43936 D Common Stock 2008-03-28 4 S 0 200 17.49 D 43736 D Common Stock 2008-03-28 4 S 0 300 17.5 D 43436 D Common Stock 2008-03-28 4 S 0 200 17.51 D 43236 D Common Stock 2008-03-28 4 S 0 100 17.52 D 44136 D Common Stock 2008-03-28 4 S 0 131 17.53 D 43005 D Common Stock 2008-03-28 4 S 0 69 17.54 D 42936 D Common Stock 2008-03-28 4 S 0 200 17.55 D 42736 D Common Stock 2008-03-28 4 S 0 100 17.56 D 42636 D Common Stock 2008-03-28 4 S 0 800 17.57 D 41836 D Common Stock 2008-03-28 4 S 0 400 17.58 D 41436 D Common Stock 2008-03-28 4 S 0 500 17.59 D 40936 D Common Stock 2008-03-28 4 S 0 636 17.6 D 40300 D Common Stock 2008-03-28 4 S 0 100 17.61 D 40200 D Common Stock 2008-03-28 4 S 0 200 17.67 D 40000 D Common Stock 2008-03-31 4 S 0 200 17.47 D 39800 D Common Stock 2008-03-31 4 S 0 100 17.59 D 39700 D Common Stock 2008-03-31 4 S 0 200 17.62 D 39500 D Common Stock 2008-03-31 4 S 0 400 17.65 D 39100 D Common Stock 2008-03-31 4 S 0 200 17.67 D 38900 D Common Stock 2008-03-31 4 S 0 300 17.75 D 38600 D Common Stock 2008-03-31 4 S 0 800 17.76 D 37800 D Common Stock 2008-03-31 4 S 0 100 17.8 D 37700 D Common Stock 2008-03-31 4 S 0 475 17.81 D 37225 D Common Stock 2008-03-31 4 S 0 100 17.84 D 37125 D On March 14, 2008, the reporting person entered into a Rule 10b5-1 trading plan to sell up to 30,000 shares of common stock for estate and tax planning objectives. The reported sales were effected pursuant to such Rule 10b5-1 plan. Fred B. Green as attorney-in-fact 2008-04-01 -----END PRIVACY-ENHANCED MESSAGE-----